1. Fowler JF, Duh MS, Chang J, Person J, Thorn D, Raut M, et al. A survey-based assessment of the prevalence and severity of chronic hand dermatitis in a managed care organization. Cutis. 2006; 77:385–392.
2. Meding B, Järvholm B. Hand eczema in Swedish adults-changes in prevalence between 1983 and 1996. J Invest Dermatol. 2002; 118:719–723.
Article
3. Diepgen TL, Andersen KE, Brandao FM, Bruze M, Bruynzeel DP, Frosch P, et al. Hand eczema classification: a cross-sectional, multicentre study of the aetiology and morphology of hand eczema. Br J Dermatol. 2009; 160:353–358.
Article
4. Agner T, Andersen KE, Brandao FM, Bruynzeel DP, Bruze M, Frosch P, et al. Hand eczema severity and quality of life: a cross-sectional, multicentre study of hand eczema patients. Contact Dermatitis. 2008; 59:43–47.
Article
5. Misiak-Galazka M, Wolska H, Rudnicka L. What do we know about palmoplantar pustulosis? J Eur Acad Dermatol Venereol. 2017; 31:38–44.
Article
6. Yoon SY, Park HS, Lee JH, Cho S. Histological differentiation between palmoplantar pustulosis and pompholyx. J Eur Acad Dermatol Venereol. 2013; 27:889–893.
Article
7. Mrowietz U, van de Kerkhof PC. Management of palmoplantar pustulosis: do we need to change? Br J Dermatol. 2011; 164:942–946.
Article
8. Diepgen TL, Pfarr E, Zimmermann T. Efficacy and tolerability of alitretinoin for chronic hand eczema under daily practice conditions: results of the TOCCATA open study comprising 680 patients. Acta Derm Venereol. 2012; 92:251–255.
Article
9. Ruzicka T, Lynde CW, Jemec GB, Diepgen T, Berth-Jones J, Coenraads PJ, et al. Efficacy and safety of oral alitretinoin (9-cis retinoic acid) in patients with severe chronic hand eczema refractory to topical corticosteroids: results of a randomized, double-blind, placebo-controlled, multicentre trial. Br J Dermatol. 2008; 158:808–817.
Article
10. Dirschka T, Reich K, Bissonnette R, Maares J, Brown T, Diepgen TL. An open-label study assessing the safety and efficacy of alitretinoin in patients with severe chronic hand eczema unresponsive to topical corticosteroids. Clin Exp Dermatol. 2011; 36:149–154.
Article
11. Kwon HI, Kim JE, Ko JY, Ro YS. Efficacy and safety of alitretinoin for chronic hand eczema in Korean patients. Ann Dermatol. 2016; 28:364–370.
Article
12. Reich K, Graff O, Mehta N. Oral alitretinoin treatment in patients with palmoplantar pustulosis inadequately responding to standard topical treatment: a randomized phase II study. Br J Dermatol. 2016; 174:1277–1281.
Article
13. Irla N, Navarini AA, Yawalkar N. Alitretinoin abrogates innate inflammation in palmoplantar pustular psoriasis. Br J Dermatol. 2012; 167:1170–1174.
Article
14. Jang S, Kim MW, Park HS, Yoon HS, Cho S. Helpful clinical features for differential diagnosis of palmoplantar pustulosis and pompholyx. Korean J Dermatol. 2017; 55:36–44.
15. Park JY, Cho EB, Park EJ, Park HR, Kim KH, Kim KJ. The histopathological differentiation between palmar psoriasis and hand eczema: a retrospective review of 96 cases. J Am Acad Dermatol. 2017; 77:130–135.
Article
16. Aydin O, Engin B, Oğuz O, Ilvan S, Demirkesen C. Non-pustular palmoplantar psoriasis: is histologic differentiation from eczematous dermatitis possible? J Cutan Pathol. 2008; 35:169–173.
Article
17. Agner T, Aalto-Korte K, Andersen KE, Foti C, Gimenéz-Arnau A, Goncalo M, et al. Classification of hand eczema. J Eur Acad Dermatol Venereol. 2015; 29:2417–2422.
Article
18. Germain P, Chambon P, Eichele G, Evans RM, Lazar MA, Leid M, et al. International Union of Pharmacology. LXIII. Retinoid X receptors. Pharmacol Rev. 2006; 58:760–772.
Article
19. Germain P, Chambon P, Eichele G, Evans RM, Lazar MA, Leid M, et al. International Union of Pharmacology. LX. Retinoic acid receptors. Pharmacol Rev. 2006; 58:712–725.
Article
20. Hanifin JM, Stevens V, Sheth P, Breneman D. Novel treatment of chronic severe hand dermatitis with bexarotene gel. Br J Dermatol. 2004; 150:545–553.
Article
21. Thestrup-Pedersen K, Andersen KE, Menné T, Veien NK. Treatment of hyperkeratotic dermatitis of the palms (eczema keratoticum) with oral acitretin. A single-blind placebo-controlled study. Acta Derm Venereol. 2001; 81:353–355.
Article
22. Shi VY, Sivamani RK, Maibach HI. Alitretinoin for the treatment of chronic hand eczema: clinical rationale. Clin Invest (Lond). 2014; 4:763–773.
Article